Asia accounted for more than 50% of the global incidence of brain and CSN tumor in 2020, with Mainland China, India, and Japan contributing to majority of the cases.
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more